p53与高危相关并精准识别套细胞淋巴瘤中的TP53错义突变
研究基于瑞典人群队列,用免疫组化(IHC)和测序分析套细胞淋巴瘤(MCL)中p53表达与TP53突变的关系及预后影响。共317例做IHC、255例测序,137例配对分析显示p53预测错义突变准确率82%、灵敏度82%、特异度100%。p53表达与TP53突变单因素分析风险比均为3.1,并与高危因素相关。
要点
- p53免疫组化预测TP53错义突变准确率82%、灵敏度82%、特异度100%(配对样本)。
- p53表达与TP53突变单因素分析风险比均为3.1,与不良生存相关。
- p53表达和TP53突变与高MCL国际预后指数、母细胞样形态及增殖相关。
核心结论
- p53免疫组化可识别携带TP53错义突变的高危套细胞淋巴瘤患者,准确率82%、灵敏度82%、特异度100%(配对样本)。
- p53表达与TP53突变单因素分析风险比均为3.1,并与高危因素相关。
研究设计与样本
- 基于瑞典人群的队列研究,共317例套细胞淋巴瘤病例进行免疫组化(IHC)检测,255例进行测序。
- 在137例配对样本中分析p53与TP53状态,样本来自两个队列。
主要发现
- p53免疫组化预测TP53错义突变的准确率为82%,灵敏度82%,特异度100%(配对样本)。
- p53表达与TP53突变单因素分析风险比均为3.1。
- p53表达和TP53突变与高MCL国际预后指数、母细胞样形态及增殖等高危因素相关。
关键数值与推荐
- p53免疫组化预测TP53错义突变:准确率82%,灵敏度82%,特异度100%(配对样本)。
- p53表达与TP53突变单因素分析风险比均为3.1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Survival for patients diagnosed with mantle cell lymphoma (MCL) has improved drastically in recent years. However, patients carrying mutations in tumour protein p53 (TP53) do not benefit from modern chemotherapy-based treatments and have poor prognosis. Thus, there is a clinical need to identify missense mutations through routine analysis to enable patient stratification. Sequencing is not widely implemented in clinical practice for MCL, and immunohistochemistry (IHC) is a feasible alternative to identify high-risk patients. The aim of the present study was to investigate the accuracy of p53 as a tool to identify patients with TP53 missense mutations and the prognostic impact of overexpression and mutations in a Swedish population-based cohort. In total, 317 cases were investigated using IHC and 255 cases were sequenced, enabling analysis of p53 and TP53 status among 137 cases divided over the two-cohort investigated. The accuracy of predicting missense mutations from protein expression was 82%, with sensitivity at 82% and specificity at 100% in paired samples. We further show the impact of p53 expression and TP53 mutations on survival (hazard ratio of 3·1 in univariate analysis for both), and the association to risk factors, such as high MCL International Prognostic Index, blastoid morphology and proliferation, in a population-based setting.
引用
- Rodrigues JM, Hassan M, Freiburghaus C, et al. p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma. Br J Haematol. 2020. PMID: 32748433. doi:10.1111/bjh.17023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。